Primary |
Constipation |
62.5% |
Atrial Fibrillation |
12.5% |
Cardiac Disorder |
12.5% |
Product Used For Unknown Indication |
12.5% |
|
Respiratory Distress |
33.3% |
Drug Dependence |
16.7% |
Drug Ineffective |
16.7% |
Dyspnoea |
16.7% |
Overdose |
16.7% |
|
Secondary |
Product Used For Unknown Indication |
60.0% |
Supraventricular Tachycardia |
20.0% |
Constipation |
10.0% |
Procedural Pain |
10.0% |
|
Constipation |
33.3% |
Diarrhoea |
33.3% |
Hallucination |
33.3% |
|
Concomitant |
Product Used For Unknown Indication |
17.2% |
Drug Use For Unknown Indication |
13.4% |
Constipation |
9.3% |
Pain |
7.4% |
Osteoporosis |
6.5% |
Depression |
6.3% |
Hypertension |
4.4% |
Colorectal Cancer Metastatic |
4.0% |
Multiple Myeloma |
3.9% |
Gastrooesophageal Reflux Disease |
3.4% |
Metastases To Bone |
3.3% |
Prophylaxis |
2.8% |
Sleep Disorder |
2.8% |
Anxiety |
2.6% |
Colorectal Cancer |
2.5% |
Hypersensitivity |
2.5% |
Back Pain |
2.0% |
Dialysis |
2.0% |
Menopause |
1.9% |
Nausea |
1.8% |
|
Weight Decreased |
17.6% |
Shock Haemorrhagic |
12.4% |
Vomiting |
8.2% |
Wheezing |
5.9% |
Urinary Tract Infection |
4.7% |
White Blood Cell Count Decreased |
4.7% |
Withdrawal Syndrome |
4.7% |
Type 2 Diabetes Mellitus |
4.1% |
Wound Drainage |
4.1% |
Electrocardiogram Qt Corrected Interval Prolonged |
3.5% |
Electrocardiogram Qt Prolonged |
3.5% |
Tooth Disorder |
3.5% |
Tooth Extraction |
3.5% |
Death |
2.9% |
Dyspnoea |
2.9% |
Nausea |
2.9% |
Ultrasound Breast Abnormal |
2.9% |
Vena Cava Thrombosis |
2.9% |
Gastric Ulcer |
2.4% |
Memory Impairment |
2.4% |
|